Ibuprofeno Farmalider

Ibuprofen, the active ingredient in Ibuprofeno Farmalider, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It treats pain, fever and inflammation in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ibuprofeno Farmalider as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that acts on inflammatory pathways to relieve several common conditions.

- Pain: Reduces mild to moderate pain such as headache, dental pain, or musculoskeletal discomfort. - Fever: Lowers elevated body temperature associated with infections or inflammatory states. - Inflammation: Decreases swelling and inflammatory response in conditions like arthritis or soft‑tissue injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Stomach upset or dyspepsia - Nausea or vomiting - Dizziness or light‑headedness - Headache - Mild rash or itching - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe allergic reactions (anaphylaxis, angioedema) - Liver injury (hepatitis, jaundice) - Kidney impairment or failure - Cardiovascular events (myocardial infarction, stroke)

Before using Ibuprofeno Farmalider, consider the following safety measures.

- Medical History Review: Assess for prior ulcers, bleeding disorders, or cardiovascular disease. - Food Intake: Take with food or milk to lessen gastrointestinal irritation. - Concomitant NSAIDs: Avoid using other NSAIDs or aspirin unless directed by a clinician. - Renal/Hepatic Monitoring: Periodically evaluate kidney and liver function during prolonged therapy. - Dose Limits: Do not exceed the prescribed maximum daily amount. - Store at ambient temperature: Keep in the original container, protect from moisture and heat.

Ibuprofen can affect the activity of several other medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened ulcer risk. - Lithium: possible increase in lithium serum levels. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may diminish antihypertensive effect. - Diuretics: potential reduction in renal function. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency. - Antihypertensive agents: possible attenuation of blood‑pressure control. - Oral hypoglycemics: may affect glucose regulation.